Catalysts for $LLY
78 tracked
May 13, 2022
approval
MOUNJARO (TIRZEPATIDE) — FDA approval
ZEPBOUND
→
Sep 30, 2021
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
Jan 28, 2021
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Sep 3, 2020
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
May 8, 2020
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Feb 21, 2020
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
Jan 15, 2019
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
Sep 21, 2018
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
Jun 29, 2018
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
Dec 12, 2017
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
Aug 1, 2017
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
Aug 1, 2017
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
Jan 27, 2017
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
Jan 27, 2017
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
Jul 27, 2015
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
Mar 9, 2015
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
Dec 19, 2014
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
Sep 18, 2014
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→